Literature DB >> 3117834

Operating characteristics of the male hypothalamo-pituitary-gonadal axis: pulsatile release of testosterone and follicle-stimulating hormone and their temporal coupling with luteinizing hormone.

J D Veldhuis1, J C King, R J Urban, A D Rogol, W S Evans, L A Kolp, M L Johnson.   

Abstract

To appraise the physiological pattern(s) of episodic testosterone and FSH release in man, we withdrew blood samples at 10-min intervals for 24-36 h in a total of 15 normal men. We subjected the resulting FSH (15 men) and testosterone (5 men) time series to 3 statistically based and mathematically independent procedures for detecting hormone pulsatility, viz. Cluster analysis, the Detect program, and Fourier transformation. The Cluster technique disclosed discrete testosterone and FSH peaks occurring at mean (+/- SEM) interpulse intervals of 112 +/- 14 and 85 +/- 3.4 min, respectively. These values were not significantly different from the mean LH interpulse interval of 95 +/- 11 min. The average durations of the testosterone and FSH pulsations were 90 +/- 11 and 59 +/- 3 min, respectively. The mean testosterone pulse amplitude reached a maximal value of 910 +/- 92 ng/dL (31.5 +/- 3.2 nmol/L), which represented a mean increase of 242 +/- 26 ng/dL (8.4 +/- 0.9 nmol/L) above the preceding nadir. FSH pulses had a maximum of 7.2 +/- 0.3 IU/L, and an incremental amplitude of 1.3 +/- 0.1 IU/L. An independent pulse detection procedure. Detect, yielded a testosterone pulse frequency of 12.3 +/- 0.8 pulses/day [P = NS vs. Cluster program (13 +/- 1.9 pulses/day)]. The Cluster and Detect estimates of FSH pulse frequency were also similar, viz. 16 +/- 1.9 and 16 +/- 0.6 pulses/day. Further analysis by Fourier transformation revealed significant circadian periodicities for serum testosterone, FSH, and LH, which had mean nyctohemeral amplitudes of 185 ng/dL (6.4 nmol/L), 0.38 IU/L, and 1.3 IU/L, respectively. Cross-correlation analyses disclosed significantly positive uncorrected cross-correlations between LH and testosterone that were maximal at a testosterone lag of 60 min (range, 50-70 min). To eliminate high intrinsic autocorrelations within the testosterone and LH time series, stepwise autoregressive fitting was employed. The resulting partial cross-correlation matrices indicated that LH concentrations at any given instant were significantly positively correlated to testosterone concentrations lagged by 10 and 20 min. Similarly, contemporaneous LH and FSH concentrations were significantly positively correlated (r = 0.40-0.89; P less than 0.001). Moreover, autoregressive modeling disclosed significantly positive partial cross-correlations between LH and FSH at a FSH lag of 10 min. In summary, we have identified significant pulsatile as well as circadian (24-h) patterns of testosterone and FSH release in normal men.(ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3117834     DOI: 10.1210/jcem-65-5-929

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  17 in total

Review 1.  The endocrine pharmacology of testosterone therapy in men.

Authors:  Michael Oettel
Journal:  Naturwissenschaften       Date:  2004-01-28

2.  Graded inhibition of pulsatile luteinizing hormone secretion by a selective gonadotropin-releasing hormone (GnRH)-receptor antagonist in healthy men: evidence that age attenuates hypothalamic GnRH outflow.

Authors:  Paul Y Takahashi; Peter Y Liu; Pamela D Roebuck; Ali Iranmanesh; Johannes D Veldhuis
Journal:  J Clin Endocrinol Metab       Date:  2005-03-01       Impact factor: 5.958

Review 3.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

Review 4.  The effect of endurance training on reproductive function in male runners. A 'volume threshold' hypothesis.

Authors:  M J De Souza; B E Miller
Journal:  Sports Med       Date:  1997-06       Impact factor: 11.136

5.  Prostate cancer risk: the significance of differences in age related changes in serum conjugated and unconjugated steroid hormone concentrations between Arab and Caucasian men.

Authors:  E O Kehinde; A O Akanji; A Memon; A A Bashir; A S Daar; K A Al-Awadi; T Fatinikun
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

Review 6.  Exercise and male factor infertility.

Authors:  J C Arce; M J De Souza
Journal:  Sports Med       Date:  1993-03       Impact factor: 11.136

7.  Nycthemeral patterns of thyroid hormones and their relationships with thyrotropin variations and sleep structure.

Authors:  B Goichot; G Brandenberger; J Saini; G Wittersheim; M Follenius
Journal:  J Endocrinol Invest       Date:  1994-03       Impact factor: 4.256

8.  Androgen levels in older men who have or who are at risk of acquiring HIV infection.

Authors:  Robert S Klein; Yungtai Lo; Nanette Santoro; Adrian S Dobs
Journal:  Clin Infect Dis       Date:  2005-11-11       Impact factor: 9.079

9.  Semi-mechanistic pharmacodynamic modeling for degarelix, a novel gonadotropin releasing hormone (GnRH) blocker.

Authors:  Pravin R Jadhav; Henrik Agersø; Christoffer W Tornøe; Jogarao V S Gobburu
Journal:  J Pharmacokinet Pharmacodyn       Date:  2006-08-08       Impact factor: 2.745

10.  Kinetics of removal of intravenous testosterone pulses in normal men.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Peter Y Liu; Paul Y Takahashi
Journal:  Eur J Endocrinol       Date:  2010-01-20       Impact factor: 6.664

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.